IL162146A0 - Use of a compound in the treatment of sleep disorders and the like, inproviding refreshedness on waking and a method for the treatment of grogginess - Google Patents

Use of a compound in the treatment of sleep disorders and the like, inproviding refreshedness on waking and a method for the treatment of grogginess

Info

Publication number
IL162146A0
IL162146A0 IL16214602A IL16214602A IL162146A0 IL 162146 A0 IL162146 A0 IL 162146A0 IL 16214602 A IL16214602 A IL 16214602A IL 16214602 A IL16214602 A IL 16214602A IL 162146 A0 IL162146 A0 IL 162146A0
Authority
IL
Israel
Prior art keywords
treatment
refreshedness
grogginess
inproviding
waking
Prior art date
Application number
IL16214602A
Other languages
English (en)
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of IL162146A0 publication Critical patent/IL162146A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
IL16214602A 2001-11-30 2002-12-02 Use of a compound in the treatment of sleep disorders and the like, inproviding refreshedness on waking and a method for the treatment of grogginess IL162146A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0128674.9A GB0128674D0 (en) 2001-11-30 2001-11-30 Treatment of sleep disorders and the like
US10/305,354 US20030134878A1 (en) 2001-11-30 2002-11-27 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
PCT/GB2002/005427 WO2003047580A1 (en) 2001-11-30 2002-12-02 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith

Publications (1)

Publication Number Publication Date
IL162146A0 true IL162146A0 (en) 2005-11-20

Family

ID=9926729

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16214602A IL162146A0 (en) 2001-11-30 2002-12-02 Use of a compound in the treatment of sleep disorders and the like, inproviding refreshedness on waking and a method for the treatment of grogginess

Country Status (13)

Country Link
US (4) US20030134878A1 (no)
EP (1) EP1455786A1 (no)
JP (1) JP2005515200A (no)
CN (1) CN1617723A (no)
AU (2) AU2002350897B2 (no)
CA (1) CA2468044A1 (no)
GB (3) GB0128674D0 (no)
IL (1) IL162146A0 (no)
NO (1) NO20042389L (no)
PL (1) PL370258A1 (no)
RU (1) RU2320340C2 (no)
WO (1) WO2003047580A1 (no)
ZA (1) ZA200404172B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312425D0 (en) * 2003-05-30 2003-07-09 Boots Co Plc Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
SG146631A1 (en) * 2003-09-03 2008-10-30 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
CN101039664A (zh) * 2004-10-14 2007-09-19 大金工业株式会社 气氛改变方法、用于该气氛改变方法的喷雾剂与喷雾装置
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
US20070299127A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
AU2008326386B2 (en) * 2007-11-21 2014-07-31 The Procter & Gamble Company Preparations, methods and kits useful for treatment of cough
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
PL3273952T3 (pl) 2015-03-26 2022-11-14 SEN-JAM Pharmaceutical LLC Kombinacja naproksenu i feksofenadyny w celu zahamowania objawów związanych z zatruciem alkoholem
GR1010679B (el) * 2023-02-03 2024-04-26 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση παρακεταμολης υπο μορφη τροχισκων ή παστιλιων με βελτιωτικο γευσης συμβατο με την παρακεταμολη

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4639459A (en) * 1983-02-01 1987-01-27 Burroughs Wellcome Co. Use of trifluoromethyl compounds
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
AR025110A1 (es) * 1999-08-13 2002-11-06 Vela Pharmaceuticals Inc Metodos y composiciones para tratar o prevenir alteraciones del sueno y enfermedades asociadas usando dosis muy bajas de ciclobenzaprina
CA2440588C (en) * 2001-03-13 2010-02-09 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
AU2002350897B2 (en) 2008-12-11
AU2002313364B2 (en) 2004-02-19
GB0228045D0 (en) 2003-01-08
WO2003047580A1 (en) 2003-06-12
CN1617723A (zh) 2005-05-18
EP1455786A1 (en) 2004-09-15
US20070015800A1 (en) 2007-01-18
GB0128674D0 (en) 2002-01-23
US20030134878A1 (en) 2003-07-17
GB0227708D0 (en) 2003-01-08
CA2468044A1 (en) 2003-06-12
GB2383537A (en) 2003-07-02
RU2004119832A (ru) 2005-04-20
US20040029927A1 (en) 2004-02-12
PL370258A1 (en) 2005-05-16
RU2320340C2 (ru) 2008-03-27
AU2002350897A1 (en) 2003-06-17
JP2005515200A (ja) 2005-05-26
GB2383537B (en) 2003-12-10
US20050282869A1 (en) 2005-12-22
ZA200404172B (en) 2005-09-01
NO20042389L (no) 2004-06-08

Similar Documents

Publication Publication Date Title
GB0312419D0 (en) Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
IL200150A0 (en) Hydroxyalkylstrach (has)-polypeptide-conjugate(has-polypeptide), a method for its production and use thereof in the manufacture of medicaments for therating anemic disorders
AU2003219931A8 (en) Sleep apnea device and method thereof
EP1582131A4 (en) ROTATING CLEANING BODY AND MANUFACTURING METHOD FOR CLEANING BODY AND ROTATING CLEANING BODY
AU2003232143A8 (en) Method and system for treating sleep apnea
AU2003271923A8 (en) Facilitating and authenticating transactions
ZA200202542B (en) Treating sleep disorders using desloratadine.
ZA200306171B (en) (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes.
EP1552769A4 (en) RECLINER DEVICE AND METHOD OF LATCHING SAID DEVICE
EP1491212A4 (en) REMEDY AGAINST SLEEP DISORDERS
IL162146A0 (en) Use of a compound in the treatment of sleep disorders and the like, inproviding refreshedness on waking and a method for the treatment of grogginess
GB2396707B (en) Facilitating and authenticating transactions
AU2003299715A8 (en) Compounds for the normalization of the sleep/wake cycle
AU2002313364A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2003215608A8 (en) Aqueous slurries of fine-particulate fillers, method for production and use thereof for the production of papers comprising fillers
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
IL150290A0 (en) The use of mirtazapine for the treatment of sleep disorders
GB0312425D0 (en) Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
IL152612A0 (en) Cyclipostins, a method for their production and the use of the same
GB0312792D0 (en) Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
GB0312793D0 (en) Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith
IL177062A0 (en) Use of 14, 15 - dihydro- 20,21 - dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders
HUP0302989A3 (en) Benzamidine derivatives and process for production thereof
SI1539160T1 (sl) Piperidin-2,6-dion pamoatne soli in njihova uporaba za zdravljenje s stresom povezanih afektivnih motenj
SI1456212T1 (sl) Derivati 6-aminomorfinana, postopek za njihovo izdelavo in njihova uporaba